(Q54493917)

30 May 2018

title

Activities of newer quinolones against Legionella group organisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135099

12 August 2023

0 references

D. Greenwood

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135099

12 August 2023

A. Laverick

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135099

12 August 2023

language of work or name

English

0 references

publication date

1 July 1983

1 reference

30 May 2018

30 July 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6135099

full work available at URL

12 August 2023

https://api.elsevier.com/content/article/PII:S014067368390257X?httpAccept=text/xml

1 reference

10.1016/S0140-6736(83)90257-X

DOI

https://api.crossref.org/works/10.1016/S0140-6736(83)90257-X

https://api.elsevier.com/content/article/PII:S014067368390257X?httpAccept=text/plain

12 August 2023

1 reference

10.1016/S0140-6736(83)90257-X

DOI

https://api.crossref.org/works/10.1016/S0140-6736(83)90257-X

12 August 2023

1 reference

30 May 2018

volume

2

1 reference

30 May 2018

issue

8344

1 reference

30 May 2018

page(s)

279-280

1 reference

30 May 2018

Susceptibility of Legionella pneumophila to twenty antimicrobial agents

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990257-X

7 January 2021

Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990257-X

7 January 2021

Clinical aspects of Legionnaires' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990257-X

7 January 2021

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990257-X

7 January 2021

Phosphate buffered, low sodium chloride blood agar medium for Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990257-X

7 January 2021

Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990257-X

7 January 2021

Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990257-X

7 January 2021

10.1016/S0140-6736(83)90257-X

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018